Publication | Open Access

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

Eortc-hncg-1559 Upstream TrialMalignant DiseaseMedicinePathologyPhase Ii StudyHead And Neck CancerI1 CohortCancer TreatmentNeck OncologyOncologyRadiation Oncology